Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : FENC    save search

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
Published: 2024-03-21 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 2.89% H: 0.88% C: -2.81%

business year update pharmaceuticals financial results
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
Published: 2024-03-19 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.45% H: 3.12% C: 0.92%

report year pharmaceuticals financial results
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Published: 2024-03-18 (Crawled : 01:00) - globenewswire.com
MC | $50.97 -0.57% 0.0% 370K twitter stocktwits trandingview |
Finance
| | O: 0.24% H: 1.34% C: -0.13%
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 8.15% H: 6.34% C: 2.98%

pharmaceuticals agreement
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 1.93% H: 5.27% C: -0.21%

revenue pharmaceuticals results
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
Published: 2024-02-01 (Crawled : 11:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.4% C: -0.6%

pedmark fda
Fennec Announces Incremental $5 Million Investment from Petrichor
Published: 2023-12-05 (Crawled : 11:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.09% H: 4.95% C: 1.65%


Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2023-11-09 (Crawled : 22:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.94% H: 3.82% C: -0.26%

pharmaceuticals
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-06 (Crawled : 11:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 13.77% H: 3.63% C: 1.4%

business update pharmaceuticals financial results
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
Published: 2023-10-30 (Crawled : 11:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 1.17% C: 1.03%

report pharmaceuticals financial results
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-19 (Crawled : 20:00) - prnewswire.com
LPCN | $5.47 2.82% 2.74% 21K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -6.12%
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 1.24% H: 4.36% C: 3.96%

conference global
Fennec Pharmaceuticals to Participate in Upcoming September 2023 Investor Conferences
Published: 2023-09-07 (Crawled : 12:00) - biospace.com/
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.13% H: 2.92% C: 1.27%

pharmaceuticals
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2023-09-07 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.13% H: 2.92% C: 1.27%

pharmaceuticals
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-03 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.58% C: -7.08%

business update pharmaceuticals financial results
Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
Published: 2023-07-31 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 8.67% C: 8.0%

report pharmaceuticals financial results
Fennec Announces Results of Annual Meeting
Published: 2023-06-12 (Crawled : 21:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 4.0% C: 3.77%

meeting results
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
Published: 2023-06-06 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 1.19% H: 3.99% C: 1.79%

authorization risk pharmaceuticals
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-11 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.39% H: 1.93% C: 1.03%

business update pharmaceuticals financial results
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
Published: 2023-05-08 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 0.12% C: -3.75%

report pharmaceuticals financial results
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
Published: 2023-03-31 (Crawled : 12:20) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 4.71% C: -4.37%

chmp positive risk pharmaceuticals
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results
Published: 2023-03-30 (Crawled : 10:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 6.1% C: 4.14%

year pharmaceuticals financial results
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.